Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / T••••••• I•••

P••••• Capital Sells T••••••• I••• to S•• D•••••••••

Sponsor to sponsorannouncedannounced Aug 22, 2022Fact
What happened
Target
T••••••• I•••
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
unknown
Target location
VA, US
Seller kind
Sponsor
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
6 named
Buy side
  • J••• G•••••••Deal partnerconfirmed
    ““P••••• is a committed investor in the diagnostics sector, and we are pleased to have worked with T•••••• to expand the company’s distribution network and the reach of its enteric diagnostic tools,” said J••• G•••••••, Partner at P••••• Capital Group.”
  • S•• D•••••••••Sponsorconfirmed
    “August 22, 2022 — P••••• C•••••• G••••• L•• (“P•••••”), a private equity firm based in Dallas and Nashville, announced today it has sold its stake in portfolio company T••••••• I••• (“T••••••”), a leading developer and manufacturer of rapid, non-invasive diagnostic tests for infectious disease, inte”
Sell side
  • P••••• C•••••• G••••• L••Sellerconfirmed
    “August 22, 2022 — P••••• C•••••• G••••• L•• (“P•••••”), a private equity firm based in Dallas and Nashville, announced today it has sold its stake in portfolio company T••••••• I••• (“T••••••”), a leading developer and manufacturer of rapid, non-invasive diagnostic tests for infectious disease, inte”
Advisory side
  • G••••• D•••Legal adviserconfirmed
    “L•••••• International served as the exclusive financial advisor and G••••• D••• served as legal counsel to T•••••• and P••••• on the transaction.”
  • L•••••• I••••••••• L••Sell-side adviserconfirmed
    “L•••••• International served as the exclusive financial advisor and G••••• D••• served as legal counsel to T•••••• and P••••• on the transaction.”
Side not stated
Evidence
“P••••• Capital Sells T••••••• I••• to S•• D•••••••••”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 16, 2026
P••••• Capital Sells T••••••• I••• to S•• D••••••••• | Private Equity Intelligence | DFX